Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: A randomised controlled trial

Diabetologia

Volumn 56, Issue 11, 2013, Pages 2383-2391

  Van Raalte, Daniël H ^a   Diamant, Michaela ^a   Ouwens, D Margriet ^b   Ijzerman, Richard G ^a   Linssen, Margot M L ^c   Guigas, Bruno ^c   Eringa, Etto C ^d   Serné, Erik H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adipokines; Glucocorticoids; Hypertension; Insulin resistance; Microvascular function; Steroid diabetes

Indexed keywords

PLACEBO; PREDNISOLONE;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSOMNIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW DRUG DOSE; MALE; MICROANGIOPATHY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISOLONE; YOUNG ADULT;

EID: 84885865576     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3016-8     Document Type: Article

References (35)

1. Gulliford MC, Charlton J, Latinovic R (2006) Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care 29:2728-2729
2. Schacke H, Docke WD, Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43
3. van Raalte DH, Ouwens DM, Diamant M (2009) Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39:81-93
4. Walker BR (2007) Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157:545-559
5. Williamson PM, Kelly JJ, Whitworth JA (1996) Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens 14(Suppl):S37-S41
6. van Raalte DH, Brands M, van der Zijl NJ et al (2011) Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia 54:2103-2112
7. Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603
8. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
9. Barrett EJ, Eggleston EM, Inyard AC et al (2009) The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 52:752-764
10. Kubota T, Kubota N, Kumagai H et al (2011) Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 13:294-307
11. Serne EH, de Jongh RT, Eringa EC, Ijzerman RG (2007) Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension 50:204-211
12. Kim JA, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888-1904
13. Li R, Zhang H, Wang W et al (2010) Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. Eur J Pharmacol 628:140-147
14. Muniyappa R, Montagnani M, Koh KK, Quon MJ (2007) Cardiovascular actions of insulin. Endocr Rev 28:463-491
15. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW (2009) Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 335:165-189
16. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD (2007) Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 14:389-402
17. Meijer RI, Serne EH, Smulders YM, van Hinsbergh VW, Yudkin JS, Eringa EC (2011) Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep 11:211-217
18. de Jongh RT, Serne EH, Ijzerman RG, de Vries G, Stehouwer CD (2004) Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109:2529-2535
19. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
20. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
21. van Raalte DH, Nofrate V, Bunck MC et al (2010) Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol 162:729-735
22. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539
23. Deacon CF, Nauck MA, Meier J, Hucking K, Holst JJ (2000) Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85:3575-3581
24. Clore JN, Thurby-Hay L (2009) Glucocorticoid-induced hyperglycemia. Endocr Pract 15:469-474
25. Keske MA, Clerk LH, Price WJ, Jahn LA, Barrett EJ (2009) Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care 32:1672-1677
26. van Genugten RE, Serne EH, Heymans MW, van Raalte DH, Diamant M (2013) Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes. Diabetologia 56:583-587
27. Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ (2001) Glucocorticoid-induced hypertension: from mouse to man. Clin Exp Pharmacol Physiol 28:993-996
28. Meijer RI, Bakker W, Alta CL et al (2013) Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes 62:590-598
29. Chen C, Jiang J, Lu JM et al (2010) Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 299:H193-H201
30. Gentile MT, Vecchione C, Marino G et al (2008) Resistin impairs insulin-evoked vasodilation. Diabetes 57:577-583
31. Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ (2009) Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 94:3543-3549
32. Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ (2006) Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55:1436-1442
33. de Jongh RT, Serne EH, Ijzerman RG, de Vries G, Stehouwer CD (2004) Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 53:2873-2882
34. Meijer RI, de Boer MP, Groen MR et al (2012) Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation 19:494-500
35. Eringa EC, Stehouwer CD, Walburg K et al (2006) Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-alpha dependence on c-Jun N-terminal kinase. Arterioscler Thromb Vasc Biol 26:274-280